Brazil's largest private bank reports April 28 with muted Wall Street backing and $2.6M net insider selling in 90 days. Short interest sits near 19M shares as options traders remain balanced.
Short interest stands at 19.0M shares as of April 23, up 1.3% day-over-day and 1.8% week-over-week. Month-over-month short bets have declined 5.8%. Utilization hovers at 8.9%, well below the 52-week high of 19.3%. Days to cover sits at 1.0 according to the latest FINRA data from April 15. Cost to borrow is minimal at 0.45% APR, down 86% from a month ago after a brief spike in late March. The short positioning reflects low conviction in either direction.
Put-call ratio printed 0.86 on April 24, tracking closely to the 20-day mean of 0.85. The z-score of 0.08 signals near-equilibrium sentiment. PCR ranged from 0.0 to 6.0 over the past year. Current levels show neither fear nor euphoria among options traders heading into the print.
The consensus rating is "sell" based on limited coverage. JP Morgan raised its price target to $9 from $8 on February 18 while maintaining an Overweight rating. That firm had previously lifted the target to $8 from $7 last November. UBS downgraded the stock to Neutral from Buy in July 2025. The mean analyst target of $8.36 sits below the current $8.85 price. Recent upgrades have been modest and followed by downgrades elsewhere.
P/E stands at 9.67, up 0.46 points over 30 days. Price-to-book sits at 2.24, rising 0.09 in the same window. EPS momentum ranks in the 51st percentile over 90 days and 53rd over 30 days. The stock scores in the 86th percentile on 12-month forward EPS growth expectations. Dividend score ranks 95th percentile. Value and quality ML ranks are unavailable.
Insiders sold $2.6M net over the past 90 days. HR Director Sergio Guillinet sold shares on April 17, 15, and 14. An officer sold $1.6M on April 8. BlackRock raised its stake by 18.6M shares to 435M as of March 31. Vanguard added 4.3M shares to reach 271M. GQG Partners and Capital Research also increased positions. Controlling shareholder Itaúsa holds 46.3% unchanged.
ITUB last reported earnings on February 5. Prior prints occurred in early February as well. The stock is down 5.7% over the past week but up 9.9% month-over-month. It gained 0.45% on April 24.
No ORTEX Alpha signals are currently active for ITUB.
See the live data behind this article on ORTEX.
Open ITUB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
